CLYM
Climb Bio
CLYM
CLYM
23 hedge funds and large institutions have $45.5M invested in Climb Bio in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.62% less ownership
Funds ownership: 61.75% → 61.14% (-0.62%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$653K | |
| 2 | +$101K | |
| 3 | +$37.3K | |
| 4 |
Renaissance Technologies
New York
|
+$29K |
| 5 |
Morgan Stanley
New York
|
+$4.61K |
Top Sellers
| 1 | -$319K | |
| 2 | -$107K | |
| 3 | -$38.5K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.7K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$1.93K |